CGRP antagonist approved to prevent migraine in adults with episodic and chronic migraine

New findings from phase 2 study published in The Lancet

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Researchers have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the […]

Monitoring how patients with multiple sclerosis or other degenerative diseases use their smartphones could provide valuable information to […]

A computational method that combines clinicodemographic variables with deep learning of pre-treatment histology images could predict response to […]